Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation

Breast cancer subtypes such as triple-negative that lack the expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 receptor (HER2), remain poorly clinically managed due to a lack of therapeutic targets. This necessitates identification and validation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Amunjela, Johanna Ndamwena, Tucker, Steven John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696453/
https://www.ncbi.nlm.nih.gov/pubmed/28954821
http://dx.doi.org/10.1042/BSR20171039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696453/
https://www.ncbi.nlm.nih.gov/pubmed/28954821
http://dx.doi.org/10.1042/BSR20171039

Ejemplares similares